![Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial]()
Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trialKallas, Esper G; Precioso, Alexander Roberto; Palacios, Ricardo; Thomé, Beatriz; Braga, PatrÃcia EmÃlia; Vanni, Tazio; Campos, Lúcia M A; Ferrari, Lilian; Mondini, Gabriella; da Graça Salomão, Maria; da Silva, Anderson; Espinola, Heloisa M; do Prado Santos, Joane; Santos, Cecilia L S; Timenetsky, Maria do Carmo S T; Miraglia, João Luiz; Gallina, Neuza M F; Weiskopf, Daniela; Sette, Alessandro; Goulart, Raphaella; Salles, Rafael Tavares; Maestri, Alvino; Sallum, Adriana Maluf Elias; Farhat, Sylvia Costa Lima; Sakita, Neusa K; Ferreira, Juliana C O A; Silveira, Cassia G T; Costa, Priscilla R; Raw, Isaias; Whitehead, Stephen S; Durbin, Anna P; Kalil, Jorge · The Lancet Infectious Diseases · 2020